Duffy noted that Omada's approach combines behavioral intelligence based on lessons from health metrics, readiness and engagement data from serving more than 100,000 GLP users, behavioral support to drive outcomes and "flexibility that enables employers to tailor their GLP-1 benefit strategies against their unique needs." The company's GLP-1 care track solution is seeing strong growth but still represents a smaller percentage of the company's overall growth so far, Shao said
Here are some common signs that your dose might need an adjustment: Still Struggling to Focus: You find it hard to concentrate on tasks like work, schoolwork, or even reading a book
Az orvos akkor rhatja fel, ha a testtmegindex (BMI) elri vagy meghaladja a 30-at, vagy ha valakinek 27 felett van a BMI-je s ehhez valamilyen testtmeggel sszefgg trsbetegsg (pldul magas vrnyoms, magas vrzsrszint, inzulinrezisztencia, 2-es tpus cukorbetegsg, obstruktv alvsi apnoe) is trsul
So that's always the challenge to really individualize our treatment